Glenn W. Welling, Director at MEDIFAST INC (MED), bought 30,168 shares at $41.50 ($1.2M) on 2017-03-14, disclosed to the SEC on 2017-03-14.
Open-market purchase of $1.2M MED by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.28 | 13,084 | $540K | 43.3% |
| 2 | $41.28 | 13,084 | $540K | 43.3% |
| 3 | $41.50 | 2,000 | $83K | 6.7% |
| 4 | $41.50 | 2,000 | $83K | 6.7% |
| Total | $41.31 avg | 30,168 | $1.2M | 100% |
| Filing → |
| HAIN | SELL | 2022-05-18 | $32.3M | — | Filing → |
| HAIN | SELL | 2022-03-04 | $45.3M | — | Filing → |
| STKL | BUY | 2022-03-04 | $235K | — | Filing → |